Atlas Trials

Combination Bevacizumab and Verteporfin (Two Different Sequences of Treatment)in Neovascular AMD

Clinical trial NCT00426998 · COMPLETED

Trial details

NCT number
NCT00426998
Sponsor
Retinal Consultants Medical Group
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Choroidal NeovascularizationMacular Degeneration
Start date
2006-04-01
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.